The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 22, 2022
Filed:
Jul. 11, 2019
Applicant:
Toru Miyazaki, Tokyo, JP;
Inventor:
Toru Miyazaki, Tokyo, JP;
Assignee:
Other;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 38/00 (2006.01); C07K 14/435 (2006.01); A61K 45/06 (2006.01); G01N 33/68 (2006.01); A61K 31/7088 (2006.01); A01K 67/027 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1761 (2013.01); A61K 38/00 (2013.01); A61K 45/06 (2013.01); C07K 14/435 (2013.01); G01N 33/6893 (2013.01); A01K 67/0276 (2013.01); A01K 2217/075 (2013.01); A01K 2227/105 (2013.01); A01K 2267/03 (2013.01); A01K 2267/035 (2013.01); A61K 31/7088 (2013.01); G01N 2333/775 (2013.01); G01N 2800/347 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention provides a prophylactic or therapeutic agent for a kidney disease, comprising Apoptosis Inhibitor of Macrophage (AIM) or a partial peptide thereof, or a nucleic acid comprising a base sequence encoding the same, or a screening method for a prophylactic or therapeutic agent for a kidney disease, comprising using an animal obtained by subjecting a non-human mammal deficient in AIM expression to unilateral ureteral obstruction or transient kidney ischemia/reperfusion and the like.